Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05504096
Other study ID # 2020/2968
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 8, 2021
Est. completion date February 18, 2023

Study information

Verified date February 2023
Source KK Women's and Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Wrist-worn wearables are used for fitness and health monitoring. This global expansion of wearable technology opens up opportunities for the diagnosis and management of chronic conditions. Diabetic patients have a two to three-fold higher risk of developing cardiovascular disease and that cardiovascular diseases accounted for 29.2.% of all deaths in Singapore. The wearable device is a promising avenue that allows for continuous monitoring of the large population of patients. Its ubiquitous and easy to use nature is an added advantage for its implementation. In this study, the investigators aim to leverage existing photoplethysmography (PPG) technology, together with artificial intelligence, to accurately monitor blood glucose levels in a continuous and non-invasive manner. A simple non-invasive tool to monitor blood glucose will be developed, and alerts will be issued when the blood glucose levels fall in the unhealthy range. A standard glucometer will be used to calibrate and validate PPG measurements of blood glucose. This study aims to recruit 500 participants from KK Women's and Children's Hospital.


Description:

Wrist-worn wearables are currently being used for fitness and health monitoring. The global expansion of wearable technology combined with smartphones access creates new questions and opportunities in the diagnosis and management of chronic conditions. High-end consumer wearables have integrated green light reflection photoplethysmography (PPG) sensors into their products. A PPG is an optically obtained plethysmogram that can be used to detect blood volume changes within mascrovasculature. Smartphones, smartwatches and heart rate tracking devices are the most commonly used devices to feature PPG. In a published literature assessing smartphone apps using PPG for heart rate monitoring, it has found that these devices are reasonably accurate, with correlation coefficients > 0.93 and mean absolute percentage errors ranging from 3.3% to 6.2%. Although PPG sensors were initially only designed to track heart rate, there has been a push to use these with algorithms in the detection of arrhythmias such as AF, and other fields. Diabetic patients have a two to three-fold higher risk of developing cardiovascular disease, and that cardiovascular diseases accounted for 29.2% of all deaths in Singapore. Wearable devices are ubiquitous, easy to use, and may allow for screening and further monitoring of a large population of patients. This research proposes to leverage PPG technology, together with artificial intelligence, and incorporate this into affordable wearable lifestyle devices, wrist-worn and in-ear, to accurately monitor continuously and non-invasively glucose levels in humans. A simple non-invasive tool to monitor blood glucose will be developed, and alerts will be issued when the blood glucose level falls in the unhealthy range. The standard glucometer will be used to calibrate and validate the PPG measurements of blood glucose. This study targets to recruit and measure the blood glucose of 500 participants from KK Women's and Children's Hospital. The primary aims of this study are: (1) Calibrate and validate PPG measurements of blood glucose, obtained both the wrist-worn and in-ear PPG devices, against the standard glucometer; (2) To develop a risk prediction model to identify subjects with blood glucose in the unhealthy range, using both subject characteristics and important features extracted from the PPG measurements using machine learning techniques. The secondary aim of this study is to validate that in-ear and wrist-worn wearables both provide relative accurate heart rate and heart rate interval measurements.


Recruitment information / eligibility

Status Completed
Enrollment 500
Est. completion date February 18, 2023
Est. primary completion date February 18, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Aged 21 years and above - Are able to walk to, take public transport to or drive to the testing site independently - Able to understand written and spoken English Exclusion Criteria: - Have difficulty in giving informed consent - Have a pacemaker - Are diagnosed with hypertension - Are on anti-hypertensive drugs - Are pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Actxa BGM Tracker (GLO2)
Wrist-worn wearable
SVT In-Ear Prototype (IEP)
In-Ear wearable

Locations

Country Name City State
Singapore KK Women's and Children's Hospital Singapore

Sponsors (2)

Lead Sponsor Collaborator
KK Women's and Children's Hospital Actxa Pte Ltd

Country where clinical trial is conducted

Singapore, 

References & Publications (5)

De Ridder B, Van Rompaey B, Kampen JK, Haine S, Dilles T. Smartphone Apps Using Photoplethysmography for Heart Rate Monitoring: Meta-Analysis. JMIR Cardio. 2018 Feb 27;2(1):e4. doi: 10.2196/cardio.8802. — View Citation

Hina, H. Nadeem and W. Saadeh, A Single LED Photoplethysmography-Based Noninvasive Glucose Monitoring Prototype System. 2019 IEEE International Symposium on Circuits and Systems (ISCAS). 2019; 1-5

Kviesis-Kipge, E., Zaharans, J., Rubenis, O., & Grabovskis, A. A photoplethysmography device for multipurpose blood circulatory system assessment. In European Conference on Biomedical Optics (p. 80900W). Optical Society of America.

Monte-Moreno E. Non-invasive estimate of blood glucose and blood pressure from a photoplethysmograph by means of machine learning techniques. Artif Intell Med. 2011 Oct;53(2):127-38. doi: 10.1016/j.artmed.2011.05.001. Epub 2011 Jun 22. — View Citation

Philip, L.A., Rajasekaran, K., & Smily Jeya Jothi, E. Continuous monitoring of blood glucose using photophlythesmograph signal. Proceedings of IEEE International Conference on Innovations in Electrical, Electronics, Instrumentation and Media Technology (ICEEIMT). 2017: 187-191

Outcome

Type Measure Description Time frame Safety issue
Primary Capillary blood glucose level using the glucometer and PPG signal readings Raw PPG signal readings obtained from the devices will be collected via an application on a phone. Capillary glucose reading will be obtained using a glucometer at the same sitting. Both the PPG signals and capillary blood glucose will be collected at the same time during the visit lasting up to 2 hour per subject. A total of 500 subjects will be recruited up to 6 months
Primary Risk prediction model of diabetes using PPG features on the wearables This study aims to develop means for non-invasive measurement of blood glucose and to assist with the early detection of diabetes among subjects who do not exhibit any noticeable signs of the disease.
PPG data will be collected from the wearables, and the standard glucometer will be used to calibrate and validate these PPG measurements of blood glucose. The objective is to calibrate and evaluate PPG as a means for assessing and monitoring blood glucose levels.
The effects of each of the PPG variables collected will be assessed by its ability to detect an increased blood glucose level, in terms of sensitivity, specificity, and positive and negative predictive values.
A risk prediction model will be developed to identify subjects with blood glucose in the unhealthy range, using both subject characteristics and important features extracted from the PPG measurements using artificial intelligence and machine learning techniques.
The study will be completed within 6 months involving 500 subjects. Data analysis and risk prediction model will be completed up to 12 months
Secondary Validate that in-ear and wrist-worn wearables both provide relative accurate heart rate and heart rate interval measurements. Smartwatches in the market have been shown to provide relatively accurate data as to the measurement of heart rate and this feature has been incorporated into newly developed smartwatches.
In this study, PPG data collected will be used to assess by its ability to detect heart rate and heart rate intervals, in terms of sensitivity, specificity, and positive and negative predictive values.
Subjects will be assessed at one visit study. Total duration of the study is 15mins for subjects whose capillary blood glucose is greater than or equal to 11.1mmol/L, and about 90minutes for those less than 11.1mmol/L.
See also
  Status Clinical Trial Phase
Completed NCT04854603 - Dairy Products With Reduced Sugar and Blood Glucose N/A
Not yet recruiting NCT05004558 - Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias N/A
Not yet recruiting NCT04018430 - Impact of Oral Glucose Tolerance Test on Extent of Hemoglobin Glycation
Completed NCT03763240 - BSE on Blood Glucose N/A
Completed NCT03686293 - A Personal Microbiome-dependent Glucose Response in Healthy Young Volunteers N/A
Completed NCT05400694 - Functional and Value-Added Dairy Products and Blood Glucose Control N/A
Terminated NCT03455985 - Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin N/A
Completed NCT05163587 - Composite Flour and Its Antdiabetic Potential N/A
Completed NCT03469869 - Effects of Balanced and Sustainable Diet Application for Insulin Resistance and Inflammation Marker of Obese People N/A
Completed NCT04961086 - Health Effect of Energy Drink Consumption N/A
Completed NCT04373863 - Assessment of Lifestyle, Blood Pressure, Cholesterol and Glycated Hemoglobin in a Specific Population
Completed NCT01901419 - Nitroglycerin Infusion During Cardiac Surgery N/A
Active, not recruiting NCT04827615 - Evaluation of the Ambuja Cement Foundation Noncommunicable Disease Program in Bathinda District of Punjab, India N/A
Completed NCT04850326 - Clinical Study to Evaluate the Short Time Efficacy of AP Green Tea Extract Affer High Fat, High Carbohydrate Diet N/A
Recruiting NCT04755062 - A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans N/A
Not yet recruiting NCT04100369 - Admission Blood Glucose as a Predictor of Morbidity and Mortality in Polytraumatized Patients
Completed NCT03412617 - Diets, Metabolic Profile and Gut Microbiota Among Indonesian Women in Minangkabau and Sundanese-ethnic Community N/A
Completed NCT05222659 - Perioperative Glucose and Insulin Changes in Major Urologic Surgeries
Completed NCT04342624 - Investigation of Cinnamon Spice on Glucose Tolerance in Subjects With Pre-diabetes N/A
Completed NCT04446754 - The Genetic Effects of rs7903146 and Dietary Intake on Type 2 Diabetes Mellitus Risk in a Healthy Population